1463 related articles for article (PubMed ID: 31722708)
1. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
4. Impact of triglyceride-glucose index on intracoronary thrombus burden in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Köktürk U; Önalan O; Somuncu MU; Akgül Ö; Uygur B; Püşüroğlu H
Nutr Metab Cardiovasc Dis; 2024 Apr; 34(4):860-867. PubMed ID: 38336545
[TBL] [Abstract][Full Text] [Related]
5. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2351-2362. PubMed ID: 32917496
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.
Rokicka D; Hudzik B; Wróbel M; Stołtny T; Stołtny D; Nowowiejska-Wiewióra A; Rokicka S; Gąsior M; Strojek K
Cardiovasc Diabetol; 2024 Apr; 23(1):147. PubMed ID: 38685054
[TBL] [Abstract][Full Text] [Related]
7. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
Cardiovasc Diabetol; 2021 Feb; 20(1):43. PubMed ID: 33573649
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
Wang L; Wang Y; Wang W; Wang Z
Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
10. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
[TBL] [Abstract][Full Text] [Related]
11. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
12. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
Liu M; Pan J; Meng K; Wang Y; Sun X; Ma L; Yu X
Sci Rep; 2024 Jan; 14(1):976. PubMed ID: 38200157
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
15. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
16. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
[TBL] [Abstract][Full Text] [Related]
17. Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C≤1.8 mmol/L who underwent percutaneous coronary intervention: a prospective cohort study.
Zhao HW; Wang Y; Wang CF; Meng QK
Front Endocrinol (Lausanne); 2023; 14():1323615. PubMed ID: 38313836
[TBL] [Abstract][Full Text] [Related]
18. Association of the triglyceride-glucose index with severity of coronary stenosis and in-hospital mortality in patients with acute ST elevation myocardial infarction after percutaneous coronary intervention: a multicentre retrospective analysis cohort study.
Lu X; Lin X; Cai Y; Zhang X; Meng H; Chen W; Yu P; Chen X
BMJ Open; 2024 Mar; 14(3):e081727. PubMed ID: 38521531
[TBL] [Abstract][Full Text] [Related]
19. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
[TBL] [Abstract][Full Text] [Related]
20. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
